Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
108,294,335
-
Total 13F shares
-
107,749,040
-
Share change
-
-1,886,654
-
Total reported value
-
$722,024,357
-
Put/Call ratio
-
40%
-
Price per share
-
$6.67
-
Number of holders
-
233
-
Value change
-
-$52,696,378
-
Number of buys
-
155
-
Number of sells
-
74
Institutional Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT) as of Q1 2025
As of 31 Mar 2025,
ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT) was held by
233 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
107,749,040 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc., VANGUARD GROUP INC, MAVERICK CAPITAL LTD, WESTFIELD CAPITAL MANAGEMENT CO LP, STATE STREET CORP, SUVRETTA CAPITAL MANAGEMENT, LLC, JANUS HENDERSON GROUP PLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
233
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.